Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
6 Patents
#2 in Cagliari
#1,398 in Italy
Neuroscienze Pharmaness S.c.a.r.l.
Forward Citations = 8
8 inventors:
Neuroscienze Pharmaness S.c.a.r.l.
Calculating rank
% Expired Patents = 83.3
EPO Patents = 5
Forward Citations = 8
Loading Chart...
Loading Chart...
8 inventors (with patents filed for the assignee):
Paolo Lazzari (6 out of 16 patents)
Stefania Ruiu (5 out of 6 patents)
Gerard Aime Pinna (5 out of 6 patents)
4. Gabriele Murineddu (4 out of 5 patents)
5. Luca Pani (3 out of 3 patents)
6. Giovanni Loriga (2 out of 2 patents)
7. Ilaria Manca (1 out of 1 patent)
8. Paolo Fadda (1 out of 1 patent)
9. Giovanni Lorgia (0 patent)
6 patents:
Company Overview
Neuroscienze Pharmaness S.c.a.r.l. is a pharmaceutical company specializing in neurosciences. They research, develop, and manufacture innovative drugs and therapies for various neurological disorders. With a team of dedicated scientists and healthcare professionals, they strive to improve the quality of life for patients suffering from conditions such as Alzheimer's, Parkinson's, and multiple sclerosis.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neuroscienze Pharmaness S.c.a.r.l.. Retrieved from https://idiyas.com/company/neuroscienze-pharmanessarl
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]